
Free Daily Podcast Summary
by Access Infinity
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
The most recent episodes — sign up to get AI-powered summaries of each one.
In this episode, we hear from Megan O'Brien, Associate Director at Access Infinity, to explore why understanding payer perception is so difficult to capture in a structured way. Megan shares how traditional KPIs like time to access and price only tell part of the story, and why the softer, more subjective elements of payer engagement, from communication frequency to corporate trust, can influence reimbursement outcomes in ways that can be challenging to track. Tune in to hear how primar...
Most Favored Nation (MFN) pricing has taken over conversations at conferences, client meetings, and boardrooms alike, but what does it actually mean in practice? In this episode, we continue the conversation on evolving US pricing policy. Host Louise Bennett is joined by three of the Access Infinity team: Leigh Ann Bruhn, Louisa Byrne, and Richard Mee. Together, they discuss the current MFN landscape from multiple angles: US payer and policy, global pricing and modelling, and ex-US strategic ...
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From the US Most Favored Nation (MFN) policy and Germany's Medical Research Act to surprising developments in Japan's pricing thresholds, Nikhil breaks down how these changes are reshaping pricing and reimbursement strategies worldwide. The conversation covers emerging regional patterns across Europe, North America, and ...
In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its implications for pharmaceutical market access. Louisa shares insights from her recent research on MFN, exploring how direct-to-consumer pricing models might actually play out in practice, and why the policy's stated goals don't always align with likely outcomes. From "brown bagging" concerns to payer behaviour shifts, this ...
In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease. Isabel shares insights from her extensive experience with due diligence assessments in orphan drug development, discussing three transformative strategies that are revolutionising how companies prove value in ultra-rare diseases. From multi-domain endpoints and visual evidence to pay...
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey into the world of market access and how her diverse experience shapes her approach to launch excellence. The conversation explores exciting developments in the industry, including the evolution of digital technologies and AI. Lizzie shares thoughtful insights on finding the righ...
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clinical Assessment (JCA) framework, which is going to significantly change the EU HTA landscape. Silvy shares key insights into some of the learnings and challenges she has encountered during this process and highlights why strong cross-functional collaboration has been...
In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's seen over the last 24 years, including multi-stakeholder capitalisation - what it means to Jie and why she feels it's important for market access leaders. The opinions shared in this podcast are Jie's own views. Send us Fan Mail
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

Your Brand Amplified
Explores the strategies and mindsets of successful entrepreneurs in business growth, marketing, and personal branding.

Marketing Happy Hour
Real marketing career advice and strategies from industry pros, with honest conversations on growth, leadership, and balance.

Authority Matters
Explores how personal branding, trust, and visibility are transforming professional influence and business growth in the digital age.

A Shot in the Arm Podcast
Ben Plumley

In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.

Proven Podcast
Charles Schwartz

The Social Impact Solutions Podcast
Practical strategies for measuring and promoting social impact to attract support and drive change.

Made for Health | Peptides | Lyme | Chronic Infections | Long Covid | Insulin Resistance | Hypermobility
A physician explores science-based approaches to treating chronic conditions and restoring health.

The Revenue House
Examines ethical marketing and business growth for purpose-driven companies through expert interviews and real-world strategies.

Inquiring Minds
Explores the intersection of science and society through critical thinking and in-depth analysis.

The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.

Prof G Markets
Daily market news and analysis on earnings, geopolitics, Big Tech, and AI with clear, no-jargon insights.
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Market Access Matters in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Market Access Matters as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Access Infinity.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Market Access Matters publishes monthly. Our AI generates a summary within hours of each new episode.
Market Access Matters covers topics including Science, Technology, Business, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.